Think in Motion
We Invest. We Actively Manage. We Inspire.
We Are MariamTek
Get Started
Catalysts for Revolutionary Health-tech
MariamTek serves as an operational investor and catalyst, specializing in revolutionary healthtech solutions. Our approach goes beyond traditional investment;
MariamTek actively engages in the operations of our healthtech ventures.
Moreover, MariamTek holds exclusive regional distribution rights to a diverse range of pioneering healthtech products, further cementing our commitment to driving innovation in the healthcare sector
Welcome to MariamTek
We navigate the frontiers of possibility, investing in, and being a catalyst for ventures poised to revolutionize the way we experience healthcare and technology.
Our team has helped breathe life into several enterprises. In investing, managing and developing these firms, we pursue a simple objective: to achieve high returns without excessive risks. We have chosen a conservative path of gradual growth. We do not believe in quick successes, because those usually do not endure.
Welcome to the future of investment strategies – where passivity gives way to the dynamic rhythm of active management.
Embark on a transformative journey with MariamTek, where we redefine the landscape of venture development.
Our investment compass is calibrated for the future, navigating the dynamic intersections of healthcare solutions and disruptive technology.
INVESTMENTS
Team
News
Portfolio
INVOLVEMENT
INFINITE
N
V
I
S
I
O
Our vision at MariamTek is to lead the way in shaping the future of healthcare through our strategic investments and operational involvement in pioneering health-tech ventures.
We aspire to be the catalyst for positive change in the healthcare sector, leveraging our exclusive regional distribution rights to bring cutting-edge products to market and improve the lives of individuals globally.
N
M
I
S
I
O
At MariamTek, our mission is to revolutionize the healthcare industry by investing in and actively nurturing groundbreaking health-tech solutions. We are committed to driving innovation and fostering the development of transformative technologies that improve patient outcomes and enhance healthcare delivery worldwide.
S
Portfolio
Selected Portfolio
We forge a collaborative partnership with you, delving deep into your objectives to craft a comprehensive business plan. Our commitment is to guide your success at every juncture, unveiling and actualizing opportunities that create enduring value. With a specialized focus on providing robust commercial, marketing, and go-to-market support, we ensure your venture is strategically positioned for sustained growth and market prominence.
MariamTek Inc.
MariamTek is a family office driven company that specializes in investing, managing, and developing various enterprises with a focus on achieving high returns while minimizing risks. The company emphasizes a conservative approach to growth, prioritizing gradual and sustainable expansion over quick successes that may not be enduring. In essence, MariamTek's team has a track record of nurturing businesses to success through careful management and strategic investment decisions, with a long-term perspective in mind.
Cardiology Institute of America
Experience the future of diagnostics with our innovative cloud-based platform, offering state-of-the-art endothelial function testing and Carotid Intima-Media Thickness (CIMT) analysis. Empowering healthcare professionals worldwide, our platform provides comprehensive insights into cardiovascular health, facilitating early detection and personalized treatment strategies. Join the global movement towards proactive healthcare management with our cutting-edge solution.
DiabetEase Clinics & Diabetes Actual A groundbreaking approach designed to provide physicians with a tool that addresses the primary cause of metabolic disorder instead of only suppressing the symptoms.
Diabetes Actual and DiabetEase Clinics are leading healthcare technology companies specializing in advanced treatments for diabetes. By leveraging patented technology and comprehensive care strategies, Diabetes Actual and Diabetease Clinics aims to restore metabolic wellness and insulin sensitivity in patients, challenging the conventional outlook on Type 2 Diabetes as a progressive disease. With a global footprint spanning 35 US clinics and 5 international treatment centers, Diabetes Actual and DiabetEase Clinics embodies hope and innovation in the fight against diabetes.
Well Cell Global
Well Cell provides a unique and groundbreaking patented approach called Physiologic Insulin Resensitization where insulin is administered as a hormone rather than a drug; addressing the primary cause of Diabetes which is metabolic failure. By utilizing insulin in a manner that bio-mimics normal physiology, this modality is designed to help physicians reduce insulin resistance which helps blood sugar more readily enter each cell and be converted into energy.
Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. Thus, our approach not only stabilizes but in many instances has reversed complications of diabetes and other metabolic disorders.
Well Cell Global is a Joint Venture Partner for our DiabetEase Clinics in the United Arab Emirates.
iLamp
iLamp is a revenue generating smart street light for home owners, small businesses, developments, villages, towns and cities all over the world.
Koning Vera Breast CT
Koning Vera Breast CT produces high-contrast real 3D images of the breast with exceptional spatial resolution.
No painful compression in a rapid 7-second exposure at radiation levels in the range of diagnostic mammogram.
artelus.com
Diabetic Retinopathy Screening (DRISTi) (CE Class 1) is an AI product designed to detect the early presence of Diabetic Retinopathy (DR) in patients during eye check up screening process instantaneously.
By cutting the cord, and creating a first of its kind, AI on a Chip we have taken DR screeing to the remotest areas of the globe. Our offline solution does not depend on the internet or the cloud and brings Point of Care diagnostics to the forgotten billions who need this service.
Diabetic Retinopathy (DR) affects over one third of all people with diabetes and is the leading cause of vision loss. Globally the prevalence of diabetes is increasing rapidly. Since Diabetic Retinopathy (DR) is a progressive disease, early detection and intervention can prevent blindness. Due to the alarming increase of Diabetes, screening for DR every year becomes important.
AMSI
Advanced Medical Solutions International (AMSI), is a US-based company that is specialized in innovative and new concepts and technologies in the biomedical field.
AMSI develops, funds, and owns patents for various medical procedures related to the diagnosis and treatment of chronic human conditions.
Our collaborators and partners are scientists, researchers and business entities from different institutions and private companies in various countries.
The mission of AMSI is to search out and help to bring to the medical community world-wide the latest cutting-edge technologies for identification, diagnosis and treatment of the more difficult medical problems currently being encountered by man.
Your company?
Will you join us? Contact us and let us have a engaging conversation on how we can team up.
5.35 Bn $
11 B $
55 Bn $
148 Bn $
Market Overview
Portfolio Potential
Artificial Intelligence Driven Healthcare market
Global Diabetes treatment
smart life
market size
Cardiology Diagnosis
MariamTek Service Offering
Welcome to the future of health-tech investment strategies – where passivity gives way to the dynamic rhythm of active management. In a world where markets pulse with constant change, our approach transcends the conventional.
We are the architects of opportunity, navigating the complexities of the financial landscape with agility, insight, and a commitment to maximizing returns. Join us on a journey where investments are not just managed; they're actively crafted for success.
Embark on a transformative journey with MariamTek, where we redefine the landscape of venture development. Our approach goes beyond the traditional realms of passive investment – we are active architects of growth.
At MariamTek, we don't just invest; we provide strategic marketing leadership, infuse capital, contribute sweat equity, appoint dynamic board members, and offer expert advisory services to fuel exponential revenue growth for our portfolio companies. With a commitment to innovation, collaboration, and hands-on involvement, we actively shape the success stories of tomorrow.
Our investment compass is calibrated for the future, navigating the dynamic intersections of healthcare solutions and disruptive technology.
With a seasoned team boasting extensive experience in these pivotal verticals, we set our sights on ventures that redefine industries. Our target investments align with our commitment to catalyzing innovation, fostering transformative healthcare solutions, and propelling groundbreaking technologies that will shape the landscape of tomorrow.
Our Team
Leadership
We work closely with you to understand your goals and then develop your entire business plan. Own success at every turn. Uncover and deliver on opportunities that build lasting value.
Anjo De Heus
emailChief Commercial and Strategy Officer
Family Office
emailSupported by a prominent medical doctor's family, our company is led by a family representative who serves as president, while day-to-day operations are overseen by our Chief Commercial and Strategy Officer.
New Layer
Non-Executive Advisory BoardRavinder Vinjamuri
NED & Advisor
Wael Osman
NED & Advisor
New Layer
Our Selected
DISTRIBUTION LICENCES
Well Cell Global Cardiology Institute of America Artelus iLamp Your Company? Coming Soon
From Our Company
Latest Company News
MariamTek Boosts Royalty Payments for Promotional License Holders
12.03.2024
MariamTek, a pioneering force at the crossroads of healthcare solutions, announces an exciting update, reaffirming commitment to innovation and shared success.
Read More
MAriamTek listed on iloxc
14.03.2024
Under the visionary leadership of the MariamTek team, the company continues to lead the charge in revolutionizing biotechnology and environmental sectors. Noteworthy achievements include the strategic spin-off of Diabetes Actual as a standalone ILOCX listing
Read More
Royalty Increase for promotional holders
14.03.2024
Link to Iloxc
Read More
All News
Our Partners
Each of Our partners is unique, each project special
Contacts
Get in Touch With Us
We work closely with you to understand your goals and then develop your entire business plan. Own success at every turn. Uncover and deliver on opportunities that build lasting value.
How to find us
MariamTek Inc.